Zoetis Inc. (NYSE: ZTS) today announced the commercial launch of Portela ® (relfovetmab) in Canada and the European Union (EU) member states. Portela is the first long-acting anti-nerve growth factor ...
Fibrosarcomas are soft tissue tumors that are potentially fatal and can develop under a cat’s skin, particularly around the hip, back, or shoulder blades. Although these tumors are often related to ...
Solensia™ is the first and only injectable monoclonal antibody (mAb) treatment for feline OA pain approved in the United States Monthly administration of Solensia controls OA pain by targeting Nerve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results